Stevens-Johnson syndrome and toxic epidermal necrolysis in childhood-onset systemic lupus erythematosus patients: a multicenter study

dc.citation.issue3]
dc.citation.volume42]
dc.contributor.authorSakamoto, A. P. [UNIFESP]
dc.contributor.authorSilva, C. A.
dc.contributor.authorSaad-Magalhaes, C.
dc.contributor.authorAlencar, A. N. [UNIFESP]
dc.contributor.authorPereira, R. M. R.
dc.contributor.authorKozu, K.
dc.contributor.authorBarbosa, C. M. P. L.
dc.contributor.authorTerreri, M. T. [UNIFESP]
dc.coverageAlges
dc.date.accessioned2020-06-26T16:30:19Z
dc.date.available2020-06-26T16:30:19Z
dc.date.issued2017
dc.description.abstractObjective: To assess Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a large population of childhood-onset systemic lupus erythematosus (cSLE) patients. Methods: Multicenter study including 852 cSLE patients followed in Pediatric Rheumatology centers in Sao Paulo, Brazil. SJS was defined as epidermal detachment below 10% of body surface area (BSA), overlap SJS-TEN 10-30% and TEN greater than 30% of BSA. Results: SJS and TEN were observed in 5/852 (0.6%) cSLE female patients, three patients were classified as SJS and two patients were classified as overlap SJS-TENen
dc.description.abstractTEN was not observed. The mean duration of SJS and overlap SJS-TEN was 15 days (range 7-22) and antibio tics induced four cases. Regarding extra-cutaneous manifestations, hepatomegaly was observed in two cSLE patients, nephritis in two and neuropsychiatric involvement and conjunctivitis were observed respectively in one patient. Hematological involvement included lymphopenia in four, leucopenia in three and thrombocytopenia in two patients. The mean SLEDAI-2K score was 14.8 (range 6-30). Laboratory analysis showed low C3, C4 and/or CH50 in two patients and the presence of anti-dsDNA autoantibody in two patients. One patient had lupus anticoagulant and another one had anticardiolipin IgG. All patients were treated with steroids and four needed additional treatment such as intravenous immunoglobulin in two patients, hydroxychloroquine and azathioprine in two and intravenous cyclophosphamide in one patient. Sepsis was observed in three cSLE patients. Two patients required intensive care and death was observed in one patient. Conclusion: Our study identified SJS and overlap SJS-TEN as rare manifestations of active cSLE associated with severe multisystemic disease, with potentially lethal outcome.en
dc.description.affiliationUniv Fed Sao Paulo, Pediat Rheumatol Unit, Sao Paulo, SP, Brazil
dc.description.affiliationUniv Sao Paulo, Pediat Rheumatol Unit, Fac Med, Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Div Rheumatol, Fac Med, Sao Paulo, Brazil
dc.description.affiliationSao Paulo State Univ UNESP, Fac Med Botucatu, Pediat Rheumatol Div, Botucatu, SP, Brazil
dc.description.affiliationHosp Infantil Darcy Vargas, Pediat Rheumatol Unit, Sao Paulo, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Pediat Rheumatol Unit, Sao Paulo, SP, Brazil
dc.description.provenanceMade available in DSpace on 2020-06-26T16:30:19Z (GMT). No. of bitstreams: 0 Previous issue date: 2017. Added 1 bitstream(s) on 2020-06-26T17:17:32Z : No. of bitstreams: 1 WOS000418501200006.pdf: 134190 bytes, checksum: 822e4c56ac15d2c03ac28c21e4868c1f (MD5)en
dc.description.sourceWeb of Science
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico
dc.description.sponsorshipFederico Foundation
dc.description.sponsorshipNucleo de Apoio a Pesquisa "Saude da Crianca e do Adolescente" of USP (NAP-CriAd)
dc.description.sponsorshipIDCNPq: 303422/2015-7
dc.description.sponsorshipIDCNPq: 301805/2013-0
dc.description.sponsorshipIDCNPq: 305068/2014-8
dc.description.sponsorshipIDCNPq: 301479/2015
dc.description.sponsorshipIDCNPq: 303752/2015-7
dc.description.sponsorshipIDFederico Foundation
dc.description.sponsorshipIDNAP-CriAd-USP
dc.format.extent250-255
dc.identifierhttp://www.actareumatologica.pt/onlinefirst_download.php?id=1170]
dc.identifier.citationActa Reumatologica Portuguesa. Alges, v. 42, n. 3, p. 250-255, 2017.
dc.identifier.fileWOS000418501200006.pdf
dc.identifier.issn0303-464X
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/53476
dc.identifier.wosWOS:000418501200006
dc.language.isoeng
dc.publisherPublisaude-Edicoes Medicas Lda
dc.relation.ispartofActa Reumatologica Portuguesa
dc.rightsACESSO ABERTO
dc.subjectStevens-Johnson syndromeen
dc.subjectToxic epidermal necrolysisen
dc.subjectChildhood-onset systemic lupus erythematosusen
dc.subjectSystemic lupus erythematosusen
dc.subjectChildhooden
dc.titleStevens-Johnson syndrome and toxic epidermal necrolysis in childhood-onset systemic lupus erythematosus patients: a multicenter studyen
dc.typeArtigo
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
WOS000418501200006.pdf
Tamanho:
131.04 KB
Formato:
Adobe Portable Document Format
Descrição:
Coleções